Filing excerpt
In July 2023, FDA issued a Warning Letter to the site based on the observations from the agency’s January 2023 inspection (2023 Warning Letter)2. In June 2025, FDA performed another re-inspection of the site. On October 31, 2025, FDA classified the June 2025 inspection as VAI... indicating that the site is in acceptable compliance with FDA’s current Good Manufacturing Practice requirements.